Guardant Health Inc GH

NAS: GH | ISIN: US40131M1099 30/04/2025

47,23 USD (-4,64%)

(-4,64%) 30/04/2025

Grafiek Guardant Health Inc

Grafiek Guardant Health Inc

1 dag1d -4,64%
1 week1w -0,38%
1 maand1m 11,21%
3 maanden3m -0,71%
6 maanden6m 105,35%
1 jaar1j 158,65%
5 jaar5j -35,72%

Guardant Health Inc in het nieuws

Toon enkel gratis nieuws

8 januari 2024 · Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa · Persbericht

13 november 2023 · Guardant Health launches Shield blood-based screening test for colorectal cancer in South Korea · Persbericht

30 mei 2023 · Guardant Health Receives Regulatory Approval from Singapore's Health Sciences Authority for Guardant360® CDx blood test for patients with advanced solid cancers · Persbericht

6 juli 2022 · Guardant Health and Adicon announce strategic partnership to offer comprehensive genomic profiling tests to accelerate development of new cancer therapies in China · Persbericht

20 juli 2021 · AI Startup Lunit Secures Investment from Guardant Health in a Strategic Funding Round · Persbericht

Profiel Guardant Health Inc

Gezondheidszorg

Medische/verpleegkundige diensten

Tandheelkundige laboratoria

CEO: Helmy Eltoukhy

Werknemers: 2.284

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe